Javascript was detected to be disabled. Javascript is required for some functions on this website.

The Institute for Innovation & Valuation in Health Care, InnoValHC, is an independent not-for-profit research organization. It was established by scientists with medical, health economic, and econometric backgrounds, as well as hands-on management experience, to analyse health economic and treatment strategies (see Profile). Learn more about the institute's Purpose and Projects.

News

Heidelberg Health Economics Winter School 2023

Please "SAVE THE DATE" for next year´s Heidelberg Health Economics Winter School, which will take place at Studio Villa Bosch from February 06-10, 2023.

Read more …

Perspective Paper on the Use of the ICER for Health Care Decision-Making Policies

"Use of the incremental cost effectiveness ratio for decision-making policies - what's the problem? A perspective paper" -- Recently published article in Expert Review of Pharmacoeconomics & Outcomes Research (online available as of April 2022).

Read more …

The Ethics of COVID-19 Vaccine Allocation

Original research article on the ethics of COVID-19 vaccine allocation published in the internationally well-known journal Public Health Ethics (online available as of March 2022).

Read more …

Evaluating DCE-WTP analysis and RS-WTP analysis in a health technology assessment of a treatment for CLN2

Original research article on "Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2]" in Expert Review of Pharmacoeconomics & Outcomes Research (Open Access; online available as of February 2022).

Read more …

Scientific Contributions to the COVID-19 Pandemic

Recently published research articles on the COVID-19 health crisis in Frontiers in Public Health (Open Access; online available as of February 2022) and in Medicine, Health Care and Philosophy (online available as of September 2021).

Read more …